Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Avextra AG

Avextra Portugal Unveils Advanced Breeding Program to Develop Proprietary THC and CBD Cultivars, Establishing a Key IP Pillar
From Avextra AG
Via GlobeNewswire
Avextra Announces the Approval of NEUROBIS by the Italian Medicines Agency: A Phase II Clinical Trial Using a Proprietary Cannabis-based Medicine for the Treatment of the Symptoms of Neurodegenerative Diseases
From Avextra AG
Via GlobeNewswire
Avextra AG and SynQube GmbH announce a Strategic Partnership in Drug Development with Cannabinoids and other Psychotropic Substances
From Avextra AG
Via GlobeNewswire
Avextra AG Announces Closing of Follow-On Capital Raise Supported by Existing and New Institutional Investors
From Avextra AG
Via GlobeNewswire
German Pain Association (DGS) and Pharmaceutical Company Avextra Join Forces to Launch Their New Study OCEAN
From Avextra AG
Via GlobeNewswire
Avextra Unveils its Alliance for Evidence and Announces its Support of BELCANTO: A Clinical Trial for Oncology Patients
From Avextra AG
Via GlobeNewswire
Avextra Signs Distribution Agreements with Pharmaceutical Partners and Commences Exports of Cannabis-based Medicines to Switzerland and Austria
From Avextra AG
Via GlobeNewswire
Avextra Continues its European Expansion, Successfully Exporting Medical Cannabis Extracts to Italy
From Avextra AG
Via GlobeNewswire
Avextra AG Announces Closing of EU 17 Million Capital Raise
From Avextra AG
Via GlobeNewswire
Avextra Successfully Exports Oil-Based Cannabis Medicines to the United Kingdom
From Avextra AG
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.